Penance India Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -76.56%
- Profit Growth -1362.48%
- Ebitda -205.13%
- Net Worth -1011.45%
- Total Assets -67.09%
About Penance India Lifescience
Penance India Lifescience Private Limited (PILPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2017 (Seven years and 11 months 12 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Satyam Pandey, Sandeepkumar Upadhyay, and Sneha Varma serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC291678
-
Company No.
291678
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Penance India Lifescience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyam Pandey
|
Director | 27-Feb-2017 | Current |
|
Sandeepkumar Upadhyay
|
Director | 30-Sep-2019 | Current |
|
Sneha Varma
|
Director | 30-Sep-2019 | Current |
Financial Performance of Penance India Lifescience.
Penance India Lifescience Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 76.56% decrease. The company also saw a substantial fall in profitability, with a 1362.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1011.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Penance India Lifescience?
Unlock access to Penance India Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Penance India Biotech Private LimitedSatyam Pandey and Sandeepkumar Upadhyay are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Penance India Lifescience?
Unlock and access historical data on people associated with Penance India Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Penance India Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penance India Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
